The study of the need for interprofessional collaboration in the health care system in Poland - experience of Lesław A. Paga Foundation.
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2015, Vol 8, Issue 2
Abstract
Background: Interprofessional collaboration (IC) in healthcare is a process by which professionals from different disciplines collaborate to provide an integrated and cohesive approach to patient care. The Lesław A. Paga Foundation for many years supports the idea of cooperation between professional, promoting it among representatives of public and social life in Poland and Eastern Europe. The foundation’s project dedicated to health care is Healthcare Leaders. Thanks to the program, participants of Healthcare Leaders have a chance to experience IC under the conditions of Polish healthcare system. Methods: A self-administered, anonymous questionnaire was distributed to 90 participants of The Healthcare Leaders project in November 2015. Comparisons were performed using e.g. chi-square tests and descriptive statistics. All statistical analyses were performed using SPSS 20.0. Results: The response rate was 42,2%. More than 80% of respondents are familiar with the concept of interprofessional collaboration in healthcare system. 36 respondents (94,7%) also agree that IC among healthcare practitioners may help to generate financial savings in the Polish healthcare system. Accordingly 34 respondents to implement IC to the healthcare system necessary is mutual respect (89,5%). This point of view is shared mainly by the people who has medical or pharmaceutical professional education (p<0,05). Conclusion: IC is well-known phenomena among participants of Healthcare Leader Program. Furher research should be considered as necessary and useful.
Authors and Affiliations
Damian Świeczkowski, Piotr Merks
Keywords
Related Articles
- EP ID EP192170
- DOI 10.7365/JHPOR.2015.2.11
- Views 116
- Downloads 0
Major Cardiovascular Consequences of Familial Hypercholesterolemia in Poland from the Economic Perspective
Background. Familial hypercholesterolemia (FH) is a genetic disease characterised by high LDL-C level with other lipid fractions levels typically correct. The disease involves the accelerated development of arteriosclero...
Real World Evidence (RWE) and Orphan drug policies in selected Central and Eastern European (CEE) Countries
The rationale for the initial project performed in the Central and Eastern European countries (CEE) was to assess and to share information from the region regarding drug policies. With this special cross countries compar...
Approach to uncertainty in health technology assessment in a Central and Eastern European country: appraisal of cancer drugs by a Polish HTA agency in presence of high crossover rates in clinical trials
Background: Health technology assessment (HTA) plays an important role in reimbursement decision making in Poland and its principles are similar to those used in other countries. However, specific inter-country differenc...
Adoption of Real World Evidence in decision-making processes on public funding of drugs in Poland
Background: The aim of the study was to assess the use and impact of RWE in decision-making processes on public funding of drugs in Poland. Methods: The analysis was based on data from the Agency for Health Technology A...
Severe allergic asthma treatment in Poland
Severe asthma is a heterogeneous disease, which, as it is now believed, requires a personalized therapy dependent on phenotype. Omalizumab, a humanized monoclonal antibody that specifically binds to free immunoglobulin E...